Campaign raises awareness about rheumatologists and rheumatic diseases.
The ACR/CHEST ILD Guidelines in Practice, a video
In collaboration with the American College of Chest Physicians, the ACR released two new comprehensive guidelines aimed at improving the screening, monitoring, and treatment of patients with interstitial lung disease (ILD) secondary to systemic autoimmune rheumatic diseases (SARDs). Recently, Sindhu R. Johnson, MD, PhD, professor of medicine at the University of Toronto, Canada, director of the Toronto Scleroderma Program and principal investigator for the guideline, and Elana J. Bernstein, MD, MSc, Florence Irving associate professor of medicine in the Division of Rheumatology at Columbia University, New York City, and co-first author, presented a webinar to talk about how the guidelines were developed and present some of the recommendations and their rationale: Watch the recording now!
EULAR 2012: MicroRNAs’ Role in Rheumatic Diseases Coming into Sharper Focus
MicroRNAs are poised to play a big role in the future understanding and treatment of rheumatoid arthritis.
Why We Are Advocates
Rheumatology advocacy efforts are paying off in 2012.
Life, Happiness, and the Pursuit of Rheumatology
What makes rheumatologists such a happy group?
ACR/ARHP Annual Meeting Networking
The 2012 ACR/ARHP Annual Meeting is an opportunity to network with rheumatology colleagues from around the world.
American College of Rheumatology Award Provides Researchers Time for Career Development
The ACR Research and Education Foundation (REF) initiated the ACR REF Rheumatology Investigator Award, which supports junior investigators as they are developing a project that will compete for NIH funding.
Join 125 Colleagues and Patients to Bring Rheumatology’s Message to Capitol Hill
Rheumatology professionals and patients attending the ACR’s Advocates for Arthritis conference will convene on Capitol Hill to speak with lawmakers about issues affecting the rheumatology community.
New Fraud Detection Probes by Medicare
The National Fraud Prevention Program aims to cut the rate of improper payment claims in half.
EULAR 2012: Rewards in Risk Factor Research
Investigations of infection and comorbidities offers hints to better understanding of rheumatoid arthritis.
Drug Diversion Concerns on the Rise
Medications removed from legitimate supply channels can affect both physician and patient.
- « Previous Page
- 1
- …
- 250
- 251
- 252
- 253
- 254
- …
- 307
- Next Page »